the Detection of Prostate Cancer in Men
Conditions
Brief summary
Prostate cancer is a significant health concern in the Middle East, including Syria, where many cases are diagnosed at advanced stages due to low awareness and inadequate screening practices. The mortality-to-incidence ratio for prostate cancer in the region is alarmingly high, indicating a pressing need for effective early detection strategies.
Detailed description
This study aims to assess the awareness, attitudes, and practices regarding prostate cancer screening among men in the middle region of Syria, with the goal of identifying barriers to early detection and informing public health interventions.
Interventions
DIAGNOSTIC_TESTPSA
Prostate-Specific Antigen test, a blood test used to measure the level of PSA in a man's blood. PSA is a protein produced by the prostate gland, and elevated levels can indicate various conditions, including prostate cancer, benign prostatic hyperplasia (BPH), or prostatitis.
DIAGNOSTIC_TESTDRE
A digital rectal exam (DRE) is a procedure where a doctor inserts a lubricated, gloved finger into the rectum to check for abnormalities.
Sponsors
Al-Hawash Private University
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
MALE
Age
40 Years to 65 Years
Inclusion criteria
* Men aged 40 years and older residing in the middle region of Syria.
Exclusion criteria
* Men with a previous diagnosis of prostate cancer.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of ptients with early signs of prostate cancer | From Participant enrolment to the end of the study at 2 weeks |
Countries
Syria
Outcome results
None listed